Stairs Dustin J, Neugebauer Nichole M, Bardo Michael T
Department of Psychology, Creighton University, Omaha, Nebraska 68178-0321, USA.
Behav Pharmacol. 2010 May;21(3):182-93. doi: 10.1097/FBP.0b013e32833a5c9e.
There appears to be a relatively narrow range of contingencies in which intravenous (i.v) infusions of nicotine will maintain responding in rats. The schedule of reinforcement typically used when investigating i.v. nicotine self-administration is a simple fixed-ratio (FR) schedule. This study determined if responding in rats could be established using a multiple schedule of either i.v. cocaine or nicotine and sucrose reinforcement. Following training of individual components with each reinforcer, rats were placed on an FR15 60-s timeout multiple schedule of cocaine (0.3 mg/kg/infusion) and sucrose (45 mg pellets) reinforcement or an FR5 60-s timeout multiple schedule of nicotine (0.03 mg/kg/infusion) and sucrose (45 mg pellets) reinforcement. Both cocaine and nicotine maintained significant levels of responding under the multiple schedule. Pretreatment with the dopamine D1 antagonist SCH 23390 increased cocaine-maintained responding, but not sucrose responding. Acute pretreatment with the nicotinic antagonist mecamylamine or SCH 23390 specifically decreased nicotine self-administration. Extinction of the individual nicotine and sucrose components resulted in decreases in responding in each component under extinction. These results indicate that i.v. nicotine maintains responding under a multiple schedule. This procedure may be useful when studying the specificity of drug pretreatments on nicotine self-administration.
静脉注射尼古丁能使大鼠维持反应的意外情况范围似乎相对较窄。在研究静脉注射尼古丁自我给药时通常使用的强化程序是简单的固定比率(FR)程序。本研究确定了是否可以使用静脉注射可卡因或尼古丁与蔗糖强化的多重程序来建立大鼠的反应。在用每种强化物对各个成分进行训练后,将大鼠置于可卡因(0.3毫克/千克/注射)和蔗糖(45毫克颗粒)强化的FR15 60秒超时多重程序或尼古丁(0.03毫克/千克/注射)和蔗糖(45毫克颗粒)强化的FR5 60秒超时多重程序中。在多重程序下,可卡因和尼古丁均维持了显著的反应水平。用多巴胺D1拮抗剂SCH 23390预处理可增加可卡因维持的反应,但不增加蔗糖维持的反应。用烟碱拮抗剂美加明或SCH 23390进行急性预处理可特异性降低尼古丁自我给药。单独的尼古丁和蔗糖成分的消退导致消退时每个成分的反应减少。这些结果表明静脉注射尼古丁在多重程序下维持反应。该程序在研究药物预处理对尼古丁自我给药的特异性时可能有用。